Re-Building Indian Pharma Inc
PM Modi's 'Make in India' campaign highlights pharma as one of the key sectors for growth but it is essential to first rebuild…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
‘IRHT would focus on Africa, Japan and Latin America as potential markets of the future’
India Brand Equity Foundation has been at the forefront of positioning Brand India Pharma and has taken up the mantle to further…
The politics behind pharma
Prime Minister Modi’s decision to review India’s position on IP laws before his first trip to the US has once again brought this…
Indian generic pharma and global regulatory challenges
Dr Gopakumar G Nair, Chief Executive Officer, Gopakumar Nair Associates talks about why the regulatory scenario in the domestic…
India Pharma Inc rates NaMo govt
The pharma sector gives the Narendra Modi-led Government full marks for good intentions but prefers to reserve judgement till it…
Analysing reactions to India’s draft pharma patent g’lines
Sankar Sundaram, pharmaceutical sciences professor at JSS University, Mysore and a patent agent with India's intellectual property…
Quality approach of pharma industry for 21st century
Dr Debabrata Roy, Former Deputy Drugs Controller (India), CDSCO, Ministry of Health and Family Welfare Government of India, gives…
Medical Technology: Vision 2025 roadmap for the way forward
Getting things right could lead to a $30 billion domestic market opportunity as well as setting up the right manufacturing…
Express Pharma hosts Idea Exchange with Dr Kenneth Thorpe on prevention of NCDs
Dr Shashank Joshi, President, Indian Diabetic Association and Dr Ratna Devi, CEO, DakshamA Health & Education were also part…
‘We will bring significant value to our customers to help us grow quickly’
GVK Biosciences has recently unveiled a new brand Clinogent in the clinical development industry. Its distinctive approach comes…
Need for HEOR in India: An overview
Dr Amit Dang, Founder and CEO, MarksMan Healthcare Solutions elaborates on concepts like HEOR, HTA, pharmacoeconomics, and gives…
Will India’s IP law and policy ‘Modi-fy’?
Yogesh Pai, Assistant Professor of Law at National Law University, Delhi, says that greater certainty and predictability in IP law…
Hope Against Hope
The Modi-led Government will present its first General Budget on July 10. Representatives of pharmaceutical companies and industry…
Cognex launches In-Sight 7010 and 7010C
In-Sight 7010 from Cognex is an entry-level smart camera vision system developed specifically for inspection tasks where vision…
Untangling Pharma Supply Chains
Pharma supply chains in India have a lot of ground to cover before becoming at par with their counterparts in the developed…
A Green Llight for GST
In India, pharma logistics is riddled with several speed breakers: poor infrastructure, multiplicity of state and central taxes,…
Falling in Line
It has been a year since the new EU GDP guidelines came into force. As the industry moves towards an increased focus on quality,…
Product launches and patent expiries to push MDD treatment market by 2023: GlobalData
MDD treatment market achieved sales of approximately $9.3 billion in 2013
M&A frenzy in pharma: Here to stay?
Mergers and Acquisitions (M&As) within the Indian pharmaceutical industry is not a new phenomenon. However, the deal between…